This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Pharmacology is one of the most fundamental aspects of medication therapy. 1] How can mastering pharmacology give sales reps a competitive advantage when meeting with prospective HCPs? Due to limited knowledge of pharmacology, the sales rep failed to properly communicate and was unable to address the physicians concerns.
The FDA’s breakthrough device programme is for medical devices or device-led combination products that provide more effective treatment or diagnosis of diseases. The aim of the programme is to expedite the development, assessment and review of medical devices in order to provide timely access to patients and healthcare providers.
“At Cala, we’ve always been committed to expanding patient access and accelerating innovation in TAPS therapy for indications beyond essential tremor,” said Renee Ryan, CEO at Cala. “By By expanding into Parkinson’s disease, we are now able to bring this powerful treatment to additional patients who suffer from action hand tremors.”
This marks the first update to NICE’s endometriosis guidelines since 2017, representing a huge milestone for patients and practitioners alike. This delay in diagnosis ultimately leads to disease progression and associated complications, such as chronic pelvic pain and infertility, which greatly affects the patients’ quality of life.
The current medications (opioid and non-opioid) often force the patients to make an unfortunate choice between efficacy and debilitating sideeffects, leading to a cycling through multiple different therapies and suboptimal treatment response. The present unmet needs within chronic pain are not met with opioid therapies.
The main label contains data that is generally in a semi-structured format, with sections covering: description of the drug, clinical pharmacology, indications (uses for the drug), contraindications (who should not take the drug), warnings and precautions, and adverse events (sideeffects). Challenges in Working with Label Data.
The system uses the patient’s EEG data to calculate a value for the amygdala-derived-EFP biomarker, and meanwhile the patient tries various mental strategies that may help to reduce the value. These treatments at times come with a long list of sideeffects, leaving many patients in search of an effective long-term solution.
During my pharmacology class, I learned that there are no safe drugs, only safe patients. This highlights the importance of taking an individualized approach to medicine and considering a patient's unique medical history, current health status, and other relevant factors when prescribing medication.
From the drug discovery phase to patient care, AI has the potential to enhance almost every stage of the product life cycle. In theory, this will allow for highly tailored, personalized therapy plans with superior efficacy and minimal sideeffects. The pharmaceutical industry has numerous use cases for AI.
Imagine a patient who takes ibuprofen to treat a headache. A drugs solubility, how the liver metabolizes it, and patient-specific factors like genetics can influence the journey of a drug. These details are the reasons why knowledge of PK and PD is fundamental to making every drug both effective and safe for every patient.
1 As they can be highly targeted in their action, they could become the treatment of choice for clinicians and patients due to the reduced risk of sideeffects. Because ADCs offer a good way to specifically deliver an effective treatment to tumour systems, this could be an improvement on the systemic impact of chemotherapy.
PSRs must possess a robust understanding of pharmacology, adeptly navigating inquiries on drug mechanisms, sideeffects, and interactions. Step into a role that revolves around educating healthcare professionals and positively impacting patient outcomes. Their mission?
Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5
Avoiding potentially misleading practices, providing accurate information and prioritizing patient welfare are important concepts reps must follow. Ethical conduct helps maintain the company’s integrity and foster trust with HCPs and patients. Ethical Conduct: In pharma sales, ethical conduct and behavior is crucial.
Education Requirements Many pharmaceutical companies prefer pharmaceutical sales candidates with a bachelor’s degree in a relevant field, such as biology, chemistry, pharmacology, or a healthcare-related discipline. You should be able to discuss the benefits, sideeffects, and uses of the medications with healthcare professionals.
“Nerivio is an excellent treatment option for our patients with migraine, especially those who do not respond to medications, or cannot tolerate their sideeffects. It’s also effective for teenagers who struggle with migraine and gives them a drug-free treatment option.
The company is aiming to enrol the first patient in the ALETTA Phase III trial in Q1 or Q2 of 2023, says Dr. Jan van der Mooren, Freya’s chief medical officer (CMO). Moreover, any potential use of Lybrido or Lybridos would also come with a screening test that will determine which of these drugs will benefit the patient, says Simon.
In January, amidst calls to improve patient safety by optimizing licensed drug formulations, the FDA released a draft guidance that signalled a departure from the most commonly used method of identifying a new therapy’s ideal dosage. For this approach, a “3+3” model is used where a study enrolls three patients into a given dose cohort.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content